We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $581M
1-Year Est. Return 28.04%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+28.04%
3 Year Est. Return
+72.9%
5 Year Est. Return
+105.39%
10 Year Est. Return
+334.2%
AUM
$363M
AUM Growth
+$27.4M
Cap. Flow
-$3.13M
Cap. Flow %
-0.86%
Top 10 Hldgs %
32.22%
Holding
170
New
6
Increased
42
Reduced
67
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.23M
2
MRK icon
Merck
MRK
+$745K
3
MPC icon
Marathon Petroleum
MPC
+$515K
4
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$429K
5
INCY icon
Incyte
INCY
+$419K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.54M
2
DE icon
Deere & Co
DE
+$1.16M
3
DD icon
DuPont de Nemours
DD
+$631K
4
ABBV icon
AbbVie
ABBV
+$602K
5
OLED icon
Universal Display
OLED
+$566K

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Healthcare 16.9%
3 Industrials 15.75%
4 Consumer Staples 8.05%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.84T
$22.7M 6.26%
309,704
-6,036
-2% -$388K
PCAR icon
2
PACCAR
PCAR
$69.6B
$22.7M 6.25%
430,307
– –
MSFT icon
3
Microsoft
MSFT
$2.85T
$17.3M 4.77%
109,835
-241
-0.2% -$35.4K
COST icon
4
Costco
COST
$415B
$8.93M 2.46%
30,389
-145
-0.5% -$43.1K
GSIE icon
5
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.86B
$8.32M 2.29%
274,914
+14,642
+6% +$429K
JNJ icon
6
Johnson & Johnson
JNJ
$633B
$8.03M 2.21%
55,042
-363
-0.7% -$49.2K
INTC icon
7
Intel
INTC
$482B
$7.72M 2.13%
129,010
+581
+0.5% +$32.5K
JPM icon
8
JPMorgan Chase
JPM
$931B
$7.47M 2.06%
53,605
-1,850
-3% -$237K
BMY icon
9
Bristol-Myers Squibb
BMY
$128B
$6.92M 1.91%
107,891
+38,972
+57% +$2.23M
MRK icon
10
Merck
MRK
$323B
$6.82M 1.88%
78,587
+9,070
+13% +$745K
NVS icon
11
Novartis
NVS
$295B
$6.5M 1.79%
68,630
-333
-0.5% -$29.9K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$3.89T
$6.3M 1.74%
94,280
+500
+0.5% +$32.3K
DE icon
13
Deere & Co
DE
$166B
$6.16M 1.7%
35,548
-6,752
-16% -$1.16M
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
$5.99M 1.65%
101,624
+3,427
+3% +$198K
WWD icon
15
Woodward
WWD
$24.7B
$5.82M 1.6%
49,137
– –
CVX icon
16
Chevron
CVX
$392B
$5.42M 1.49%
45,023
+164
+0.4% +$19.3K
QCOM icon
17
Qualcomm
QCOM
$176B
$5.32M 1.47%
60,333
-2,380
-4% -$199K
HD icon
18
Home Depot
HD
$325B
$5.24M 1.44%
24,011
– –
XOM icon
19
ExxonMobil
XOM
$657B
$4.94M 1.36%
70,826
-2,663
-4% -$184K
BIIB icon
20
Biogen
BIIB
$29.8B
$4.86M 1.34%
16,389
– –
BAC icon
21
Bank of America
BAC
$434B
$4.58M 1.26%
130,126
-4,225
-3% -$137K
PEP icon
22
PepsiCo
PEP
$185B
$4.55M 1.25%
33,315
– –
USB icon
23
US Bancorp
USB
$99.1B
$4.43M 1.22%
74,787
-50
-0.1% -$2.89K
VZ icon
24
Verizon
VZ
$188B
$4.28M 1.18%
69,741
+1,060
+2% +$63.9K
IBM icon
25
IBM
IBM
$200B
$4.17M 1.15%
32,559
-484
-1% -$62.9K
1
2 3 4 5

Similar funds

TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
TCMX
Technology Crossover Management XI Menlo Park, California $582M AUM 17.87% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
GF
Goodman Financial Houston, Texas $582M AUM 22.09% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Mengis Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Mengis Capital Management held 170 positions worth $363M, up 8.2% from $336M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Mengis Capital Management's Q4 2019 filing shows 6 new, 42 increased, 67 reduced and 4 closed positions. Its largest new stake was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K. The largest sale was Celgene Corp, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Mengis Capital Management's largest Q4 2019 buy was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K.
  • Mengis Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.23M increase.
  • Mengis Capital Management's biggest Q4 2019 reduction was Deere & Co, cutting an estimated $1.16M.
  • Mengis Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $2.54M.
  • Mengis Capital Management's ten largest holdings make up 32% of its $363M portfolio in Q4 2019.
  • Mengis Capital Management opened 6 new positions and closed 4 in Q4 2019.
  • Mengis Capital Management's portfolio value rose 8.2% quarter-over-quarter to $363M.

Based on Mengis Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.